Literature DB >> 29115896

Drugging DNA repair to target T-ALL cells.

Yashodhara Dasgupta1, Konstantin Golovine1, Margaret Nieborowska-Skorska1, Li Luo2, Ksenia Matlawska-Wasowska3, Charles G Mullighan4, Tomasz Skorski1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29115896      PMCID： PMC5940588          DOI： 10.1080/10428194.2017.1397662

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  15 in total

1.  BRCA2-dependent and independent formation of RAD51 nuclear foci.

Authors:  Madalena Tarsounas; Derek Davies; Stephen C West
Journal:  Oncogene       Date:  2003-02-27       Impact factor: 9.867

2.  ATM prevents the persistence and propagation of chromosome breaks in lymphocytes.

Authors:  Elsa Callén; Mila Jankovic; Simone Difilippantonio; Jeremy A Daniel; Hua-Tang Chen; Arkady Celeste; Manuela Pellegrini; Kevin McBride; Danny Wangsa; Andrea L Bredemeyer; Barry P Sleckman; Thomas Ried; Michel Nussenzweig; André Nussenzweig
Journal:  Cell       Date:  2007-06-28       Impact factor: 41.582

3.  Disruption of Runx1 and Runx3 leads to bone marrow failure and leukemia predisposition due to transcriptional and DNA repair defects.

Authors:  Chelsia Qiuxia Wang; Vaidehi Krishnan; Lavina Sierra Tay; Desmond Wai Loon Chin; Cai Ping Koh; Jing Yuan Chooi; Giselle Sek Suan Nah; Linsen Du; Bindya Jacob; Namiko Yamashita; Soak Kuan Lai; Tuan Zea Tan; Seiichi Mori; Ichiro Tanuichi; Vinay Tergaonkar; Yoshiaki Ito; Motomi Osato
Journal:  Cell Rep       Date:  2014-07-24       Impact factor: 9.423

Review 4.  Playing the end game: DNA double-strand break repair pathway choice.

Authors:  J Ross Chapman; Martin R G Taylor; Simon J Boulton
Journal:  Mol Cell       Date:  2012-08-24       Impact factor: 17.970

5.  BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance.

Authors:  A Slupianek; C Schmutte; G Tombline; M Nieborowska-Skorska; G Hoser; M O Nowicki; A J Pierce; R Fishel; T Skorski
Journal:  Mol Cell       Date:  2001-10       Impact factor: 17.970

6.  Notch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cells.

Authors:  M Masiero; S Minuzzo; I Pusceddu; L Moserle; L Persano; V Agnusdei; V Tosello; G Basso; A Amadori; S Indraccolo
Journal:  Leukemia       Date:  2011-01-25       Impact factor: 11.528

7.  Intracellular reactive oxygen species are essential for PI3K/Akt/mTOR-dependent IL-7-mediated viability of T-cell acute lymphoblastic leukemia cells.

Authors:  A Silva; A Gírio; I Cebola; C I Santos; F Antunes; J T Barata
Journal:  Leukemia       Date:  2011-04-01       Impact factor: 11.528

8.  The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.

Authors:  Jinghui Zhang; Li Ding; Linda Holmfeldt; Gang Wu; Sue L Heatley; Debbie Payne-Turner; John Easton; Xiang Chen; Jianmin Wang; Michael Rusch; Charles Lu; Shann-Ching Chen; Lei Wei; J Racquel Collins-Underwood; Jing Ma; Kathryn G Roberts; Stanley B Pounds; Anatoly Ulyanov; Jared Becksfort; Pankaj Gupta; Robert Huether; Richard W Kriwacki; Matthew Parker; Daniel J McGoldrick; David Zhao; Daniel Alford; Stephen Espy; Kiran Chand Bobba; Guangchun Song; Deqing Pei; Cheng Cheng; Stefan Roberts; Michael I Barbato; Dario Campana; Elaine Coustan-Smith; Sheila A Shurtleff; Susana C Raimondi; Maria Kleppe; Jan Cools; Kristin A Shimano; Michelle L Hermiston; Sergei Doulatov; Kolja Eppert; Elisa Laurenti; Faiyaz Notta; John E Dick; Giuseppe Basso; Stephen P Hunger; Mignon L Loh; Meenakshi Devidas; Brent Wood; Stuart Winter; Kimberley P Dunsmore; Robert S Fulton; Lucinda L Fulton; Xin Hong; Christopher C Harris; David J Dooling; Kerri Ochoa; Kimberly J Johnson; John C Obenauer; William E Evans; Ching-Hon Pui; Clayton W Naeve; Timothy J Ley; Elaine R Mardis; Richard K Wilson; James R Downing; Charles G Mullighan
Journal:  Nature       Date:  2012-01-11       Impact factor: 49.962

9.  Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia.

Authors:  Irene Homminga; Rob Pieters; Anton W Langerak; Johan J de Rooi; Andrew Stubbs; Monique Verstegen; Maartje Vuerhard; Jessica Buijs-Gladdines; Clarissa Kooi; Petra Klous; Pieter van Vlierberghe; Adolfo A Ferrando; Jean Michel Cayuela; Brenda Verhaaf; H Berna Beverloo; Martin Horstmann; Valerie de Haas; Anna-Sophia Wiekmeijer; Karin Pike-Overzet; Frank J T Staal; Wouter de Laat; Jean Soulier; Francois Sigaux; Jules P P Meijerink
Journal:  Cancer Cell       Date:  2011-04-12       Impact factor: 31.743

10.  Small-Molecule Disruption of RAD52 Rings as a Mechanism for Precision Medicine in BRCA-Deficient Cancers.

Authors:  Gurushankar Chandramouly; Shane McDevitt; Katherine Sullivan; Tatiana Kent; Antonio Luz; J Fraser Glickman; Mark Andrake; Tomasz Skorski; Richard T Pomerantz
Journal:  Chem Biol       Date:  2015-11-05
View more
  10 in total

1.  Novel allosteric PARP1 inhibitors for the treatment of BRCA-deficient leukemia.

Authors:  Elizabeth Hewlett; Monika Toma; Katherine Sullivan-Reed; John Gordo; Tomasz Sliwinski; Alexei Tulin; Wayne E Childers; Tomasz Skorski
Journal:  Med Chem Res       Date:  2020-04-19       Impact factor: 1.965

2.  Genomic Analysis Reveals the Prognostic and Immunotherapeutic Response Characteristics of Ferroptosis in Lung Squamous Cell Carcinoma.

Authors:  Yinhe Feng; Xingyu Xiong; Yubin Wang; Ding Han; Chunfang Zeng; Hui Mao
Journal:  Lung       Date:  2022-05-05       Impact factor: 2.584

Review 3.  Epigenetic Underpinnings of Inflammation: A Key to Unlock the Tumor Microenvironment in Glioblastoma.

Authors:  Nian Chen; Cheng Peng; Dan Li
Journal:  Front Immunol       Date:  2022-04-29       Impact factor: 8.786

4.  Phytochemicals of Rhus spp. as Potential Inhibitors of the SARS-CoV-2 Main Protease: Molecular Docking and Drug-Likeness Study.

Authors:  Yousery E Sherif; Sami A Gabr; Nasser M Hosny; Ahmad H Alghadir; Rayan Alansari
Journal:  Evid Based Complement Alternat Med       Date:  2021-02-27       Impact factor: 2.629

5.  Biocomputational Assessment of Natural Compounds as a Potent Inhibitor to Quorum Sensors in Ralstonia solanacearum.

Authors:  Sunil Kumar; Khurshid Ahmad; Santosh Kumar Behera; Dipak T Nagrale; Anurag Chaurasia; Manoj Kumar Yadav; Sneha Murmu; Yachana Jha; Mahendra Vikram Singh Rajawat; Deepti Malviya; Udai B Singh; Raja Shankar; Minaketan Tripathy; Harsh Vardhan Singh
Journal:  Molecules       Date:  2022-05-09       Impact factor: 4.411

Review 6.  Clinical Efficacy and Potential Mechanisms of Acupoint Stimulation Combined With Chemotherapy in Combating Cancer: A Review and Prospects.

Authors:  Shanshan Li; Suhong Zhao; Yi Guo; Yuanzhen Yang; Jin Huang; Jiaqi Wang; Shanshan Lu; Bin Wang; Chao Chai; Zhifang Xu; Yenlie Chin
Journal:  Front Oncol       Date:  2022-04-25       Impact factor: 5.738

7.  Betulinic acid increases lifespan and stress resistance via insulin/IGF-1 signaling pathway in Caenorhabditis elegans.

Authors:  Haiyan Chen; Rongji Li; Feng Zhao; Li Luan; Tiantian Han; Zhong Li
Journal:  Front Nutr       Date:  2022-07-29

Review 8.  Targeting autophagy regulation in NLRP3 inflammasome-mediated lung inflammation in COVID-19.

Authors:  Yuan-Yuan Yong; Li Zhang; Yu-Jiao Hu; Jian-Ming Wu; Lu Yan; Yi-Ru Pan; Yong Tang; Lu Yu; Betty Yuen-Kwan Law; Chong-Lin Yu; Jie Zhou; Mao Li; Da-Lian Qin; Xiao-Gang Zhou; An-Guo Wu
Journal:  Clin Immunol       Date:  2022-08-06       Impact factor: 10.190

9.  An efficient enzyme-triggered controlled release system for colon-targeted oral delivery to combat dextran sodium sulfate (DSS)-induced colitis in mice.

Authors:  Shangyong Li; Mengfei Jin; Yanhong Wu; Samil Jung; Dandan Li; Ningning He; Myeong-Sok Lee
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

Review 10.  Exploring the Oral Microbiome in Rheumatic Diseases, State of Art and Future Prospective in Personalized Medicine with an AI Approach.

Authors:  Silvia Bellando-Randone; Edda Russo; Vincenzo Venerito; Marco Matucci-Cerinic; Florenzo Iannone; Sabina Tangaro; Amedeo Amedei
Journal:  J Pers Med       Date:  2021-06-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.